FDA Adverse Event Malfunction Summary report: N

JADA SYSTEM

MDR report key: 14280042 · Received May 4, 2022

Report

Report Number
3017425145-2022-00081
Event Type
Malfunction
Date Received
May 4, 2022
Date of Event
April 2, 2022
Report Date
May 3, 2022
Manufacturer
ALYDIA HEALTH
Product Code
OQY
UDI-DI
00850017882003
PMA / PMN Number
K201199
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NC, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

BASED ON THE OVERALL INFORMATION CURRENTLY PROVIDED IN THIS REPORT, THERE IS A REASONABLE POSSIBILITY THAT A POTENTIAL MALFUNCTION (REPORTED AS "BLOOD CLOTTED IN TUBING - HAD TO REPLACE TUBING.") HAS OCCURRED WITH THE JADA SYSTEM WHEREBY IF THE SUSPECTED MALFUNCTION WERE TO RECUR AT A TIME WHEN THE PATIENT WAS NOT UNDER CLOSE OBSERVATION, THIS MALFUNCTION COULD POSSIBLY CAUSE OR CONTRIBUTE TO A DEATH OR SERIOUS INJURY. OUT OF AN ABUNDANCE OF CAUTION, THE COMPANY WILL REPORT THIS CASE AS A MALFUNCTION MDR. PER THE JADA SYSTEM IFU, "SIGNS OF PATIENT DETERIORATION OR FAILURE TO IMPROVE INDICATE THE NEED FOR REASSESSMENT AND POSSIBLY MORE AGGRESSIVE TREATMENT AND MANAGEMENT OF POSTPARTUM HEMORRHAGE (PPH)/ABNORMAL POSTPARTUM UTERINE BLEEDING.", "EVALUATE FOR LACERATIONS, RETAINED PRODUCTS OF CONCEPTION, OR OTHER CAUSES OF BLEEDING PRIOR TO USING JADA." AND "JADA IS NOT A SUBSTITUTE FOR SURGICAL MANAGEMENT AND FLUID RESUSCITATION OF LIFE-THREATENING PPH/ABNORMAL POSTPARTUM UTERINE BLEEDING."

Description of Event or Problem · 0

ALYDIA HEALTH RECEIVED A COMPLETED JADA EXPERIENCE SURVEY FORM ON 04/07/2022 THAT REPORTED JADA STOPPED THE POSTPARTUM HEMORRHAGE (PPH) BUT NOTED "BLOOD CLOTTED IN TUBING - HAD TO REPLACE TUBING." IN THE AREA ON THE SURVEY DESIGNATED FOR FEEDBACK WHEN 'JADA DID NOT STOP BLEEDING'. THIS PATIENT IN THIS CASE IS DESCRIBED AS MULTIPAROUS WITH HAVING OBESITY, HYPERTENSION, PRE-ECLAMPSIA, AND FIBROIDS. SHE HAS A HISTORY OF PPH WITH PREVIOUS DELIVERIES. SHE HAD A VAGINAL INDUCTION AND HER PPH STARTED WITHIN ONE HOUR AFTER DELIVERY. PRIOR TO JADA USE SHE RECEIVED CYTOTEC (600 UNITS) AND TXA (1 G). THE PATIENT'S BLOOD LOSS PRIOR TO JADA USE REPORTED AS 1357 ML. THE CERVICAL SEAL WAS REPORTED AS FILLED WITH 120 ML OF STERILE FLUID. JADA WAS REPORTED TO HAVE CONTROLLED THE PPH BLEEDING IN "GREATER THAN 10 MINUTES." ADDITIONAL INFORMATION PROVIDED AFTER A PHONE DISCUSSION, "MOM DID FINE, SHE HAD A KNOWN FIBROID 10 CM, ON MAG, PREVIOUS PPH, GUSHED, DID THE SWEEP 1-2 TIMES BEFORE PLACEMENT, NO METHERGINE DUE TO HYPERTENSION, USED TXA, CLOTTING IN THE TUBE, NOT A GOOD SUCTION, 80 MM HG INCREASED TO 90 MM THEN EXCHANGED WALL TUBING, FLUSHED AND WORKED MUCH BETTER, BY THE TIME SHE PLACED JADA THERE WAS 1000 ML BLOOD LOSS , 300 ML IN CANNISTER, PATIENT WENT TO OB SPECIAL CARE UNIT BECAUSE SHE WAS ON MAG, TXA MAY HAVE CHANGED THE BLOOD, VERY AGGRESSIVE BLEED, 5-10 MINUTES AFTER PLACENTAL DELIVERY JADA WAS PLACED, HEMABATE GIVEN AFTER DEVICE PLACED." THE LOT NUMBER IS NOT CURRENTLY AVAILABLE FOR THIS EVENT. MULTIPLE REQUESTS WERE SENT TO THIS SITE FOR LOT NUMBER AND OR DEVICE RETENTION, NO RESPONSE TO THIS REQUEST TO DATE. A GOOD FAITH EFFORT TO AN OBTAIN LOT NUMBER HAS BEEN ATTEMPTED. THIS SITE ONLY HAS THE JADA 1001 MODEL CURRENTLY. THIS REPORT WILL BE AMENDED IF WE RECEIVE ADDITIONAL INFORMATION REGARDING THIS EVENT. FOLLOWING THE ATTEMPT TO TREAT PPH THAT UTEROTONICS FAILED TO TREAT, A JADA DEVICE WAS INSERTED. THE HEALTH CARE PROVIDER REPORTED JADA STOPPED THE BLEEDING WITHIN TEN MINUTES, THERE WAS 325 ML IN THE JADA CANISTER; AND "BLOOD CLOTTED IN TUBING - HAD TO REPLACE TUBING." WE ARE REPORTING THIS AS A MDR IN AN ABUNDANCE OF CAUTION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
410724 JADA SYSTEM INTRAUTERINE VACUUM CONTRACTION SYSTEM OQY ALYDIA HEALTH JADA - 1001 00850017882003

Patients

Seq Age Sex Outcome Treatment
1 Female